NASDAQ:CASM - CAS Medical Systems Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$2.12 +0.13 (+6.53 %)
(As of 08/17/2018 08:58 AM ET)
Previous Close$1.99
Today's Range$1.99 - $2.13
52-Week Range$0.59 - $2.70
Volume163,448 shs
Average Volume125,399 shs
Market Capitalization$76.77 million
P/E Ratio-7.85
Dividend YieldN/A
CAS Medical Systems logoCAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Receive CASM News and Ratings via Email

Sign-up to receive the latest news and ratings for CASM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments


Debt-to-Equity Ratio-0.66
Current Ratio3.23
Quick Ratio2.84


Trailing P/E Ratio-7.85
Forward P/E Ratio-7.85
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.76 million
Price / Sales3.25
Cash FlowN/A
Price / CashN/A
Book Value($0.40) per share
Price / Book-5.30


EPS (Most Recent Fiscal Year)($0.27)
Net Income$-2,330,000.00
Net Margins-7.46%
Return on EquityN/A
Return on Assets-35.81%


Outstanding Shares28,750,000
Market Cap$76.77 million

CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions

What is CAS Medical Systems' stock symbol?

CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."

How were CAS Medical Systems' earnings last quarter?

CAS Medical Systems Inc (NASDAQ:CASM) released its earnings results on Thursday, August, 2nd. The medical technology company reported ($0.08) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical technology company had revenue of $5.29 million for the quarter, compared to analysts' expectations of $5.18 million. View CAS Medical Systems' Earnings History.

When is CAS Medical Systems' next earnings date?

CAS Medical Systems is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for CAS Medical Systems.

Who are some of CAS Medical Systems' key competitors?

Who are CAS Medical Systems' key executives?

CAS Medical Systems' management team includes the folowing people:
  • Mr. Thomas M. Patton, Pres, CEO & Director (Age 54)
  • Mr. Jeffery A. Baird, CFO & Sec. (Age 64)
  • Mr. John K. Gamelin, VP of R&D (Age 53)
  • Dr. Paul B. Benni, Chief Scientific Officer (Age 50)
  • Susan Carron, Director of Corp. Communications

Has CAS Medical Systems been receiving favorable news coverage?

Press coverage about CASM stock has trended somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. CAS Medical Systems earned a media and rumor sentiment score of 0.19 on Accern's scale. They also assigned media stories about the medical technology company an impact score of 47.58 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for CAS Medical Systems.

Who are CAS Medical Systems' major shareholders?

CAS Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional investors include Acuta Capital Partners LLC (18.31%), EAM Investors LLC (1.39%), Renaissance Technologies LLC (1.34%) and BlackRock Inc. (0.29%). Company insiders that own CAS Medical Systems stock include James E Flynn and John Gamelin. View Institutional Ownership Trends for CAS Medical Systems.

Which institutional investors are buying CAS Medical Systems stock?

CASM stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Renaissance Technologies LLC, BlackRock Inc. and Acuta Capital Partners LLC. View Insider Buying and Selling for CAS Medical Systems.

How do I buy shares of CAS Medical Systems?

Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CAS Medical Systems' stock price today?

One share of CASM stock can currently be purchased for approximately $2.12.

How big of a company is CAS Medical Systems?

CAS Medical Systems has a market capitalization of $76.77 million and generates $18.76 million in revenue each year. The medical technology company earns $-2,330,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.

How can I contact CAS Medical Systems?

CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]

MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2018 by Staff

Featured Article: Trading Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.